Article
The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
The Journal of endocrinology - 1 Oct 2011
Choi Hyun-Jeung, Kim Tae Yong, Chung Namhyun, Yim Ji Hye, Kim Won Gu, Kim Jin A, Kim Won Bae, Shong Young Kee
Abstract excerpt
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) is an activator of 5'-AMP-activated protein kinase (AMPK), which plays a role in the maintenance of cellular energy homeostasis. Activated AMPK inhibits the protein kinase mechanistic target of rapamycin, thereby reducing the extent of protein translation and suppressing both cell growth and cell cycle entry. Recent reports indicate that AMPK-mediated growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
